The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?


Sen S., Tuncer A., ÖZAKBAŞ S., Uzunkopru C., Baba C., Demir S., ...More

MULTIPLE SCLEROSIS AND RELATED DISORDERS, vol.58, 2022 (Peer-Reviewed Journal) identifier identifier

  • Publication Type: Article / Article
  • Volume: 58
  • Publication Date: 2022
  • Doi Number: 10.1016/j.msard.2021.103399
  • Journal Name: MULTIPLE SCLEROSIS AND RELATED DISORDERS
  • Journal Indexes: Science Citation Index Expanded, Scopus, EMBASE, MEDLINE
  • Keywords: Neuromyelitis optica spectrum disorders, Myelin oligodendrocyte glycoprotein antibody-associated disorders, Disease modifying treatment, Coronavirus, SARS-CoV-2

Abstract

Background: COVID-19 is a multisystemic infection with variables consequences depending on individual and comorbid conditions. The course and outcomes of COVID-19 during neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) are not clearly known.